Computational investigation unveils pathogenic LIG3 non-synonymous mutations and therapeutic targets in acute myeloid leukemia.

Single nucleotide polymorphisms (SNPs) in DNA repair genes can impair protein structure and function, contributing to disease development, including cancer. Non-synonymous SNPs (nsSNPs) in the LIG3 gene are linked to genomic instability and increased cancer risk, particularly acute myeloid leukemia...

Full description

Saved in:
Bibliographic Details
Main Authors: Md Arif Hossen, Umme Mim Sad Jahan, Md Arju Hossain, Khalid Hossain Asif, Ahona Rahman, Sabbir Ahmed, Md Moin Uddin, Md Faisal Amin, Muhammad Abdul Barik, Mohammod Johirul Islam, Mohammad Kamruzzaman, Soharth Hasnat, Mohammad Nasir Uddin, Tofazzal Islam, M Nazmul Hoque
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0320550
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850218654238507008
author Md Arif Hossen
Umme Mim Sad Jahan
Md Arju Hossain
Khalid Hossain Asif
Ahona Rahman
Sabbir Ahmed
Md Moin Uddin
Md Faisal Amin
Muhammad Abdul Barik
Mohammod Johirul Islam
Mohammad Kamruzzaman
Soharth Hasnat
Mohammad Nasir Uddin
Tofazzal Islam
M Nazmul Hoque
author_facet Md Arif Hossen
Umme Mim Sad Jahan
Md Arju Hossain
Khalid Hossain Asif
Ahona Rahman
Sabbir Ahmed
Md Moin Uddin
Md Faisal Amin
Muhammad Abdul Barik
Mohammod Johirul Islam
Mohammad Kamruzzaman
Soharth Hasnat
Mohammad Nasir Uddin
Tofazzal Islam
M Nazmul Hoque
author_sort Md Arif Hossen
collection DOAJ
description Single nucleotide polymorphisms (SNPs) in DNA repair genes can impair protein structure and function, contributing to disease development, including cancer. Non-synonymous SNPs (nsSNPs) in the LIG3 gene are linked to genomic instability and increased cancer risk, particularly acute myeloid leukemia (AML). This study aims to identify the most deleterious nsSNPs in the LIG3 and potential therapeutic targets for DNA repair restoration in AML. We employed different computational approaches to analyze LIG3 nsSNPs and pathogenicity. Subsequently, molecular docking, molecular dynamics simulation (MDS), gene expression and clinical validation of LIG3 were performed to evaluate ligand-binding affinities, protein stability and to identify discriminatory gene signatures. Out of the 12,191 mapped SNPs, 132 were nsSNPs located in the coding region. Among these, 18 nsSNPs were identified as detrimental including 12 destabilizing and 6 stabilizing nsSNPs. Nine cancer-associated nsSNPs, including L381R and R528C, were predicted due to their structural and functional impacts. Further analysis revealed key phosphorylation and methylation sites, such as 529S and 224R. MDS highlighted stable interactions of compounds AHP-MPC and DM-BFC with wild-type and R528C mutant LIG3 proteins, while R671G and V781M mutants showed instability. Protein-protein interaction networks and functional enrichment linked LIG3 to DNA repair pathways. Kaplan-Meier analysis associated high LIG3 expression with improved survival in breast cancer and AML, suggesting its role as a prognostic biomarker. This study emphasizes the mutation-specific effects of LIG3 nsSNPs on protein stability and ligand interactions. We recommend identifying DM-BFC to advance personalized medicine approaches for targeting deleterious variants, following in-vitro and in-vivo validation for AML treatment.
format Article
id doaj-art-b7e946e6ded049919bed4f1b7b8ca394
institution OA Journals
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-b7e946e6ded049919bed4f1b7b8ca3942025-08-20T02:07:39ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01206e032055010.1371/journal.pone.0320550Computational investigation unveils pathogenic LIG3 non-synonymous mutations and therapeutic targets in acute myeloid leukemia.Md Arif HossenUmme Mim Sad JahanMd Arju HossainKhalid Hossain AsifAhona RahmanSabbir AhmedMd Moin UddinMd Faisal AminMuhammad Abdul BarikMohammod Johirul IslamMohammad KamruzzamanSoharth HasnatMohammad Nasir UddinTofazzal IslamM Nazmul HoqueSingle nucleotide polymorphisms (SNPs) in DNA repair genes can impair protein structure and function, contributing to disease development, including cancer. Non-synonymous SNPs (nsSNPs) in the LIG3 gene are linked to genomic instability and increased cancer risk, particularly acute myeloid leukemia (AML). This study aims to identify the most deleterious nsSNPs in the LIG3 and potential therapeutic targets for DNA repair restoration in AML. We employed different computational approaches to analyze LIG3 nsSNPs and pathogenicity. Subsequently, molecular docking, molecular dynamics simulation (MDS), gene expression and clinical validation of LIG3 were performed to evaluate ligand-binding affinities, protein stability and to identify discriminatory gene signatures. Out of the 12,191 mapped SNPs, 132 were nsSNPs located in the coding region. Among these, 18 nsSNPs were identified as detrimental including 12 destabilizing and 6 stabilizing nsSNPs. Nine cancer-associated nsSNPs, including L381R and R528C, were predicted due to their structural and functional impacts. Further analysis revealed key phosphorylation and methylation sites, such as 529S and 224R. MDS highlighted stable interactions of compounds AHP-MPC and DM-BFC with wild-type and R528C mutant LIG3 proteins, while R671G and V781M mutants showed instability. Protein-protein interaction networks and functional enrichment linked LIG3 to DNA repair pathways. Kaplan-Meier analysis associated high LIG3 expression with improved survival in breast cancer and AML, suggesting its role as a prognostic biomarker. This study emphasizes the mutation-specific effects of LIG3 nsSNPs on protein stability and ligand interactions. We recommend identifying DM-BFC to advance personalized medicine approaches for targeting deleterious variants, following in-vitro and in-vivo validation for AML treatment.https://doi.org/10.1371/journal.pone.0320550
spellingShingle Md Arif Hossen
Umme Mim Sad Jahan
Md Arju Hossain
Khalid Hossain Asif
Ahona Rahman
Sabbir Ahmed
Md Moin Uddin
Md Faisal Amin
Muhammad Abdul Barik
Mohammod Johirul Islam
Mohammad Kamruzzaman
Soharth Hasnat
Mohammad Nasir Uddin
Tofazzal Islam
M Nazmul Hoque
Computational investigation unveils pathogenic LIG3 non-synonymous mutations and therapeutic targets in acute myeloid leukemia.
PLoS ONE
title Computational investigation unveils pathogenic LIG3 non-synonymous mutations and therapeutic targets in acute myeloid leukemia.
title_full Computational investigation unveils pathogenic LIG3 non-synonymous mutations and therapeutic targets in acute myeloid leukemia.
title_fullStr Computational investigation unveils pathogenic LIG3 non-synonymous mutations and therapeutic targets in acute myeloid leukemia.
title_full_unstemmed Computational investigation unveils pathogenic LIG3 non-synonymous mutations and therapeutic targets in acute myeloid leukemia.
title_short Computational investigation unveils pathogenic LIG3 non-synonymous mutations and therapeutic targets in acute myeloid leukemia.
title_sort computational investigation unveils pathogenic lig3 non synonymous mutations and therapeutic targets in acute myeloid leukemia
url https://doi.org/10.1371/journal.pone.0320550
work_keys_str_mv AT mdarifhossen computationalinvestigationunveilspathogeniclig3nonsynonymousmutationsandtherapeutictargetsinacutemyeloidleukemia
AT ummemimsadjahan computationalinvestigationunveilspathogeniclig3nonsynonymousmutationsandtherapeutictargetsinacutemyeloidleukemia
AT mdarjuhossain computationalinvestigationunveilspathogeniclig3nonsynonymousmutationsandtherapeutictargetsinacutemyeloidleukemia
AT khalidhossainasif computationalinvestigationunveilspathogeniclig3nonsynonymousmutationsandtherapeutictargetsinacutemyeloidleukemia
AT ahonarahman computationalinvestigationunveilspathogeniclig3nonsynonymousmutationsandtherapeutictargetsinacutemyeloidleukemia
AT sabbirahmed computationalinvestigationunveilspathogeniclig3nonsynonymousmutationsandtherapeutictargetsinacutemyeloidleukemia
AT mdmoinuddin computationalinvestigationunveilspathogeniclig3nonsynonymousmutationsandtherapeutictargetsinacutemyeloidleukemia
AT mdfaisalamin computationalinvestigationunveilspathogeniclig3nonsynonymousmutationsandtherapeutictargetsinacutemyeloidleukemia
AT muhammadabdulbarik computationalinvestigationunveilspathogeniclig3nonsynonymousmutationsandtherapeutictargetsinacutemyeloidleukemia
AT mohammodjohirulislam computationalinvestigationunveilspathogeniclig3nonsynonymousmutationsandtherapeutictargetsinacutemyeloidleukemia
AT mohammadkamruzzaman computationalinvestigationunveilspathogeniclig3nonsynonymousmutationsandtherapeutictargetsinacutemyeloidleukemia
AT soharthhasnat computationalinvestigationunveilspathogeniclig3nonsynonymousmutationsandtherapeutictargetsinacutemyeloidleukemia
AT mohammadnasiruddin computationalinvestigationunveilspathogeniclig3nonsynonymousmutationsandtherapeutictargetsinacutemyeloidleukemia
AT tofazzalislam computationalinvestigationunveilspathogeniclig3nonsynonymousmutationsandtherapeutictargetsinacutemyeloidleukemia
AT mnazmulhoque computationalinvestigationunveilspathogeniclig3nonsynonymousmutationsandtherapeutictargetsinacutemyeloidleukemia